BCAX
NASDAQ · Biotechnology
Bicara Therapeutics Inc
$18.22
-0.17 (-0.92%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
-20.4% upside
Low Target
$9.75
Average Target
$14.50
High Target
$19.19
Current Price
$18.22
Current
$18.22
$18.22
Target
$14.50
$14.50
$9.75
$14.50 avg
$19.19
Scenario Analysis
Bear Case
$9.75
-46.5%
Low target
Base Case
$14.50
-20.4%
Avg target
Bull Case
$19.19
+5.3%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$20.25
-10.0% from high
52-Week Low
$7.80
+133.6% from low
Target vs 52W High
$14.50
-28.4% vs high
Next Earnings Report
Mar 30, 2026 · Before Market Open
3d
until earnings
EPS Est: $-0.68
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |